Netta Jagpal - Dec 20, 2024 Form 4 Insider Report for InMed Pharmaceuticals Inc. (INM)

Role
Chief Financial Officer
Signature
/s/ Eric A. Adams, attorney-in-fact for Ms. Netta Jagpal
Stock symbol
INM
Transactions as of
Dec 20, 2024
Transactions value $
$0
Form type
4
Date filed
12/23/2024, 09:26 AM
Previous filing
Feb 27, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INM Employee Stock Option (Right to Buy) Award $0 +3.75K +150% $0.00 6.25K Dec 20, 2024 Common shares 3.75K $4.14 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were granted on 12/20/2024 and will vest in equal installments monthly over 36 months (1/36 per month).
F2 On November 14, 2024, the common stock of InMed was reverse split on a 1-for-20 basis. This number reflects that reverse stock split.